[Aspects of immunosuppressive therapy of multiple sclerosis].
The report consists of a survey of the present state of the immunosuppressive therapy for multiple sclerosis. In agreement with the experiences of other clinics a combination therapy of cyclophosphamid and prednison is favoured.
D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011241:Prednisone
Aspekte der immunosuppressiven Therapie der Multiplen Sklerose.